Protalix BioTherapeutics, Inc. - COM (PLX)

Historical Portfolio Holders from Q4 2019 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
5.61M
Holdings value Q2 2024
$6.56M
Value change Q2 2024
-$4.73M
Grand Portfolio weight change Q2 2024
0%
Number of holders
60
Number of buys Q2 2024
37
Number of sells Q2 2024
-37
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 5.61M $6.56M -$4.73M $1.17 61
2024 Q1 9.45M $11.9M -$696K $1.26 61
2023 Q4 9.85M $17.5M +$1.24M $1.78 66
2023 Q3 9.17M $15.2M -$98.2K $1.66 61
2023 Q2 8.97M $17.9M +$12M $2.00 66
2023 Q1 2.94M $6.15M +$448K $2.10 34
2022 Q4 3.57M $4.87M +$112K $1.37 27
2022 Q3 3.55M $3.7M +$2.4M $1.04 25
2022 Q2 1.19M $1.3M +$26.6K $1.09 28
2022 Q1 1.22M $1.29M -$1.77M $1.06 28
2021 Q4 2.92M $2.44M -$1.65M $0.83 24
2021 Q3 4.41M $5.91M +$92.8K $1.33 31
2021 Q2 4.31M $8.24M -$19.3M $1.91 30
2021 Q1 8.82M $39.3M +$21.2M $4.46 35
2020 Q4 4.09M $14.8M -$3.21M $3.63 22
2020 Q3 4.76M $18.4M -$1.93M $3.87 25
2020 Q2 5.26M $19.8M -$2.82M $3.79 26
2020 Q1 6M $14.1M +$12.6M $2.35 15
2019 Q4 644K $2.11M +$2.11M $3.28 7